Vac­citech con­fi­den­tial­ly files for Nas­daq IPO — re­port; Sanofi recom­mits to so­cial caus­es, launch­es glob­al non­prof­it

An­oth­er biotech is re­port­ed­ly head­ed to Nas­daq, one that plays a promi­nent role in the Covid-19 vac­cine race.

Com­ing from the shores of Britain, Vac­citech con­fi­den­tial­ly filed for an IPO on Wednes­day, per a re­port from the Fi­nan­cial Times. The com­pa­ny hasn’t filed any pa­per­work with the SEC just yet, and it’s un­clear what kind of raise they’re es­ti­mat­ing. FT not­ed that the com­pa­ny could price as ear­ly as this month, how­ev­er.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER